BR9713998A - Uso de 17beta-dihidroequilenina como um antioxidante - Google Patents

Uso de 17beta-dihidroequilenina como um antioxidante

Info

Publication number
BR9713998A
BR9713998A BR9713998-0A BR9713998A BR9713998A BR 9713998 A BR9713998 A BR 9713998A BR 9713998 A BR9713998 A BR 9713998A BR 9713998 A BR9713998 A BR 9713998A
Authority
BR
Brazil
Prior art keywords
dihydroequilenin
antioxidant
17beta
dihydroekylene
pharmaceutically acceptable
Prior art date
Application number
BR9713998-0A
Other languages
English (en)
Inventor
Steven Jay Adelman
Dorothy Helen Prozialeck
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9713998A publication Critical patent/BR9713998A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"USO DE 17BETA-DIHIDROEQUILENINA COMO UM ANTIOXIDANTE"<D>. Esta invenção fornece um método usando 17ß-dihidroequilenina ou um sal de éster 17ß-dihidroequilenina-3-sulfato aceitável farmaceuticamente como um antioxidante.
BR9713998-0A 1996-12-10 1997-12-05 Uso de 17beta-dihidroequilenina como um antioxidante BR9713998A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76306596A 1996-12-10 1996-12-10
PCT/US1997/022153 WO1998025625A1 (en) 1996-12-10 1997-12-05 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT

Publications (1)

Publication Number Publication Date
BR9713998A true BR9713998A (pt) 2000-02-29

Family

ID=25066793

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713998-0A BR9713998A (pt) 1996-12-10 1997-12-05 Uso de 17beta-dihidroequilenina como um antioxidante

Country Status (13)

Country Link
EP (1) EP0944390A1 (pt)
JP (1) JP2001506627A (pt)
KR (1) KR20000069400A (pt)
CN (1) CN1239891A (pt)
AR (1) AR010343A1 (pt)
AU (1) AU744098C (pt)
BR (1) BR9713998A (pt)
CA (1) CA2272074A1 (pt)
HU (1) HUP0000476A3 (pt)
IL (1) IL130070A0 (pt)
TW (1) TW422693B (pt)
WO (1) WO1998025625A1 (pt)
ZA (1) ZA9711054B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030013692A1 (en) * 2001-01-19 2003-01-16 Gullans Steven R. Methods of treating neurological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin
WO1997008187A1 (en) * 1995-08-30 1997-03-06 Eli Lilly And Company N-butylsulfonate esters of estrogens

Also Published As

Publication number Publication date
CA2272074A1 (en) 1998-06-18
CN1239891A (zh) 1999-12-29
AR010343A1 (es) 2000-06-07
HUP0000476A2 (hu) 2000-10-28
JP2001506627A (ja) 2001-05-22
IL130070A0 (en) 2000-02-29
AU7845298A (en) 1998-07-03
TW422693B (en) 2001-02-21
HUP0000476A3 (en) 2001-01-29
ZA9711054B (en) 1999-06-09
AU744098C (en) 2003-07-31
KR20000069400A (ko) 2000-11-25
AU744098B2 (en) 2002-02-14
EP0944390A1 (en) 1999-09-29
WO1998025625A1 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
BR9902086A (pt) Formulações farmacêuticas.
BR9813228A (pt) Formulação de 2-metil-tieno-benzodiazepina
ES2179881T3 (es) Antagonistas de endotelina.
AU1126500A (en) Marker for indicating the location of identified tissue
ES2182088T3 (es) Antagonista de la endotelina.
DE69730043D1 (de) Implantierbare eletrodenleitung
DE69727384D1 (de) Polykatonische sterin-derivate zur transfektion
YU15299A (sh) Farmaceutski sastavi
ID27036A (id) Pirazolopirimidinona penghambat cgmp pde5 untuk pengobatan kelainan fungsi seksual
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
BR9712491A (pt) Composições cosméticas
AU3168197A (en) Surgical kit for implantation of an injection site
NO962491L (no) Orale formuleringer av S(+)-etodolac
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
IT1282627B1 (it) Procedimento per la preparazione di perfluoropoliossialchileni perossidici
AU3351097A (en) Medical laser guidance apparatus
AU694663B2 (en) Agents for use against parasitic protozoa
AU4127597A (en) Biochemical markers of the human endometrium
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
BR9714384A (pt) Uso de equeilenina como um antioxidante
AU2881399A (en) N1-modified glycopeptides
FR2756888B3 (fr) Corps de palier
BR9713998A (pt) Uso de 17beta-dihidroequilenina como um antioxidante
BR9714382A (pt) 17alfa-diidroequilina para uso como um antioxidante médico
PT835656E (pt) Preparado combinado contendo tramadolo e um antagonista de calcio

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1888 DE 13/03/2007.